RhumbLine Advisers
NXGN

RhumbLine Advisers’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

RhumbLine Advisers’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-173,702
Closed -$4.12M – 4303
2023
Q3 		$4.12M Sell
173,702
-61
-0% -$1.15K ﹤0.01% 1466
2023
Q2 		$2.82M Buy
173,763
+6,093
+4% +$101K ﹤0.01% 1718
2023
Q1 		$2.92M Buy
167,670
+4,133
+3% +$74.3K ﹤0.01% 1613
2022
Q4 		$3.07M Sell
163,537
-5,320
-3% -$103K ﹤0.01% 1566
2022
Q3 		$2.99M Buy
168,857
+5,444
+3% +$94.5K ﹤0.01% 1543
2022
Q2 		$2.85M Sell
163,413
-3,345
-2% -$63.8K ﹤0.01% 1566
2022
Q1 		$3.49M Sell
166,758
-2,706
-2% -$51.8K ﹤0.01% 1535
2021
Q4 		$3.02M Buy
169,464
+4,420
+3% +$71K ﹤0.01% 1657
2021
Q3 		$2.33M Sell
165,044
-18,607
-10% -$289K ﹤0.01% 1820
2021
Q2 		$3.05M Sell
183,651
-10,188
-5% -$183K ﹤0.01% 1715
2021
Q1 		$3.51M Buy
193,839
+3,531
+2% +$69.7K ﹤0.01% 1605
2020
Q4 		$3.47M Buy
190,308
+19,723
+12% +$313K ﹤0.01% 1563
2020
Q3 		$2.17M Sell
170,585
-2,770
-2% -$35.4K ﹤0.01% 1635
2020
Q2 		$1.9M Buy
173,355
+9,089
+6% +$94.2K ﹤0.01% 1763
2020
Q1 		$1.72M Buy
164,266
+3,135
+2% +$40.4K ﹤0.01% 1625
2019
Q4 		$2.59M Buy
161,131
+8,046
+5% +$133K ﹤0.01% 1659
2019
Q3 		$2.4M Buy
153,085
+2,960
+2% +$49.2K ﹤0.01% 1636
2019
Q2 		$2.99M Buy
150,125
+2,800
+2% +$52.3K 0.01% 1481
2019
Q1 		$2.48M Buy
147,325
+334
+0.2% +$5.79K ﹤0.01% 1587
2018
Q4 		$2.23M Buy
146,991
+27,647
+23% +$474K ﹤0.01% 1570
2018
Q3 		$2.4M Sell
119,344
-1,840
-2% -$39K ﹤0.01% 1561
2018
Q2 		$2.36M Buy
121,184
+5,143
+4% +$81.3K ﹤0.01% 1586
2018
Q1 		$1.58M Buy
116,041
+1,569
+1% +$20.7K ﹤0.01% 1725
2017
Q4 		$1.55M Buy
114,472
+14,436
+14% +$207K ﹤0.01% 1755
2017
Q3 		$1.57M Buy
100,036
+2,435
+2% +$39.3K ﹤0.01% 1752
2017
Q2 		$1.68M Buy
97,601
+2,439
+3% +$37.1K ﹤0.01% 1681
2017
Q1 		$1.45M Buy
95,162
+25,538
+37% +$376K ﹤0.01% 1735
2016
Q4 		$916K Buy
69,624
+4,123
+6% +$52.8K ﹤0.01% 1900
2016
Q3 		$741K Buy
65,501
+3,235
+5% +$38.8K ﹤0.01% 1983
2016
Q2 		$742K Buy
62,266
+3,318
+6% +$44.6K ﹤0.01% 1968
2016
Q1 		$898K Buy
58,948
+720
+1% +$10.9K ﹤0.01% 1863
2015
Q4 		$939K Buy
58,228
+4,605
+9% +$67.2K ﹤0.01% 1846
2015
Q3 		$669K Buy
53,623
+1,667
+3% +$22.9K ﹤0.01% 2042
2015
Q2 		$861K Sell
51,956
-1,765
-3% -$28.4K ﹤0.01% 1967
2015
Q1 		$858K Sell
53,721
-36,539
-40% -$604K ﹤0.01% 1957
2014
Q4 		$1.41M Sell
90,260
-2,500
-3% -$36.5K ﹤0.01% 1577
2014
Q3 		$1.28M Sell
92,760
-5,900
-6% -$89.5K ﹤0.01% 1598
2014
Q2 		$1.58M Buy
98,660
+3,006
+3% +$47.5K ﹤0.01% 1527
2014
Q1 		$1.61M Buy
95,654
+1,860
+2% +$33.7K ﹤0.01% 1491
2013
Q4 		$1.98M Sell
93,794
-360
-0.4% -$8.11K 0.01% 1378
2013
Q3 		$2.05M Sell
94,154
-15,033
-14% -$321K 0.01% 1329
2013
Q2 		$2.04M Buy
+109,187
New +$1.99M 0.01% 1293

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

RhumbLine Advisers's NXGN Position: Q4 2023 in Review

RhumbLine Advisers sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 173,702 shares — an estimated $4.12M sold.

RhumbLine Advisers first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $4.12M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • RhumbLine Advisers reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 173,702 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $4.12M.
  • RhumbLine Advisers first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • RhumbLine Advisers's NextGen Healthcare, Inc. Common Stock position peaked at $4.12M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.